Spatiotemporal induction patterns of cytokine and related immune signal molecule mRNAs in response to intrastriatal injection of lipopolysaccharide

Journal of Neuroimmunology

Volumn 109, Issue 2, 2000, Pages 245-260

  Stern, Edra L ^a   Quan, Ning ^a   Proescholdt, Margit G ^a   Herkenham, Miles ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Brain inflammation; Cytokine; Endotoxin; Interleukin 1; Intracerebral injection

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; ENDOTOXIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE EXPRESSION; IMMUNE RESPONSE; IN SITU HYBRIDIZATION; INFLAMMATION; MALE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034703441     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00318-0     Document Type: Erratum

References (89)

1. Andersson P.B., Perry V.H., Gordon S. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience. 48:1992;169-186.
2. Aono K., Isobe K., Kiuchi K., et al. In vitro and in vivo expression of inducible nitric oxide synthase during experimental endotoxemia: involvement of other cytokines. J. Cell. Biochem. 65:1997;349-358.
3. Arend W.P., Malyak M., Guthridge C.J., et al. Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 16:1998;27-55.
4. Ashkenazi A., Marsters S.A., Capon D.J., et al. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc. Natl. Acad. Sci. USA. 88:1991;10535-10539.
5. Bell M.D., Perry V.H. Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammagen or during acute neuronal degeneration. J. Neurocytol. 24:1995;695-710.
6. Bell M.D., Lopez-Gonzalez R., Lawson L., et al. Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS. J. Neurocytol. 23:1994;605-613.
7. Bell M.D., Taub D.D., Perry V.H. Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience. 74:1996;283-292.
8. Benveniste E.N. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am. J. Physiol. 263:1992;C1-16.
9. Benveniste E.N. Cytokines: influence on glial cell gene expression and function. Chem. Immunol. 69:1997;31-75.
10. Benveniste E.N. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. 75:1997;165-173.
11. Benveniste E.N., Sparacio S.M., Norris J.G., et al. Induction and regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroimmunol. 30:1990;201-212.
12. Benveniste E.N., Huneycutt B.S., Shrikant P., et al. Second messenger systems in the regulation of cytokines and adhesion molecules in the central nervous system. Brain Behav. Immun. 9:1995;304-314.
13. Beutler B., Milsark I.W., Cerami A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 229:1985;869-871.
14. Brady L.S., Lynn A.B., Herkenham M., et al. Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain. J. Neurosci. 14:1994;4951-4964.
15. Breder C.D., Hazuka C., Ghayur T., et al. Regional induction of tumor necrosis factor α expression in the mouse brain after systemic lipopolysaccharide administration. Proc. Natl. Acad. Sci. USA. 91:1994;11393-11397.
16. Bruce A.J., Boling W., Kindy M.S., et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2:1996;788-794.
17. Buttini M., Boddeke H. Peripheral lipopolysaccharide stimulation induces interleukin-1 β messenger RNA in rat brain microglial cells. Neuroscience. 65:1995;523-530.
18. Campbell I.L. Neuropathogenic actions of cytokines assessed in transgenic mice. Int. J. Dev. Neurosci. 13:1995;275-284.
19. Campbell I.L., Abraham C.R., Masliah E., et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA. 90:1993;10061-10065.
20. Chan S.H., Perussia B., Gupta J.W., et al. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:1991;869-879.
21. Cheng Q., Cant C.A., Moll T., et al. NK-κB subunit-specific regulation of the IκBα promoter. J. Biol. Chem. 269:1994;13551-13557.
22. Creasey A.A., Stevens P., Kenney J., et al. Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli. Circ. Shock. 33:1991;84-91.
23. Cserr H.F., Ostrach L.H. Bulk flow of interstitial fluid after intracranial injection of blue dextran 2000. Exp. Neurol. 45:1974;50-60.
24. Day H.E., Akil H. Differential pattern of c-fos mRNA in rat brain following central and systemic administration of interleukin-1β: implications for mechanism of action. Neuroendocrinology. 63:1996;207-218.
25. Fabry Z., Raine C.S., Hart M.N. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol. Today. 15:1994;218-224.
26. Frei K., Siepl C., Groscurth P., et al. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur. J. Immunol. 17:1987;1271-1278.
27. Garcion E., Sindji L., Montero-Menei C., et al. Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3. Glia. 22:1998;282-294.
28. Ghersi-Egea J.F., Finnegan W., Chen J.L., et al. Rapid distribution of intraventricularly administered sucrose into cerebrospinal fluid cisterns via subarachnoid velae in rat. Neuroscience. 75:1996;1271-1288.
29. Hansen M.K., Taishi P., Chen Z., et al. Vagotomy blocks the induction of interleukin-1β (IL-1β) mRNA in the brain of rats in response to systemic IL-1β J. Neurosci. 18:1998;2247-2253.
30. Hayes M.P., Murphy F.J., Burd P.R. Interferon-gamma-dependent inducible expression of the human interleukin-12 p35 gene in monocytes initiates from a TATA-containing promoter distinct from the CpG-rich promoter active in Epstein-Barr virus-transformed lymphoblastoid cells. Blood. 91:1998;4645-4651.
31. Herkenham M., Lee H.Y., Baker R.A. Temporal and spatial patterns of c-fos mRNA induced by intravenous interleukin-1: a cascade of non-neuronal cellular activation at the blood-brain barrier. J. Comp. Neurol. 400:1998;175-196.
32. Higgins G.A., Olschowka J.A. Induction of interleukin-1β mRNA in adult rat brain. Brain Res. Mol. Brain Res. 9:1991;143-148.
33. Hurd Y.L., Herkenham M. The human neostriatum shows compartmentalization of neuropeptide gene expression in dorsal and ventral regions: an in situ hybridization histochemical analysis. Neuroscience. 64:1995;571-586.
34. Ilyin S.E., Sonti G., Gayle D., et al. Regulation of brain interleukin-1β (IL-1β) system mRNAs in response to pathophysiological concentrations of IL-1β in the cerebrospinal fluid. J. Mol. Neurosci. 7:1996;169-181.
35. Jann B., Reske K., Jann K. Heterogeneity of lipopolysaccharides. Analysis of polysaccharide chain lengths by sodium dodecylsulfate-polyacrylamide gel electrophoresis. Eur. J. Biochem. 60:1975;239-246.
36. Kirkpatrick J.B. Textbook of Neuropathology. 1997;Williams and Wilkins.
37. Klein M.A., Moller J.C., Jones L.L., et al. Impaired neuroglial activation in interleukin-6 deficient mice. Glia. 19:1997;227-233.
38. Lacroix S., Feinstein D., Rivest S. The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathol. 8:1998;625-640.
39. Lee S.C., Liu W., Dickson D.W., et al. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1β J. Immunol. 150:1993;2659-2667.
40. Lesslauer W., Tabuchi H., Gentz R., et al. Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur. J. Immunol. 21:1991;2883-2886.
41. Lieberman A.P., Pitha P.M., Shin H.S., et al. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. USA. 86:1989;6348-6352.
42. Liu T., McDonnell P.C., Young P.R., et al. Interleukin-1 beta mRNA expression in ischemic rat cortex. Stroke. 24:1993;1746-1750.
43. Liu T., Clark R.K., McDonnell P.C., et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke. 25:1994;1481-1488.
44. Manetti R., Parronchi P., Giudizi M.G., et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1993;1199-1204.
45. May M.J., Ghosh S. Signal transduction through NF-κB. Immunol. Today. 19:1998;80-88.
46. McCarron R.M., Wang L., Racke M.K., et al. Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J. Neuroimmunol. 43:1993;23-30.
47. Merrill J.E., Benveniste E.N. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19:1996;331-338.
48. Miller M.A., Kolb P.E., Raskind M.A. A method for simultaneous detection of multiple mRNAs using digoxigenin and radioisotopic cRNA probes. J. Histochem. Cytochem. 41:1993;1741-1750.
49. Müller J.M., Ziegler-Heitbrock H.W., Baeuerle P.A. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology. 187:1993;233-256.
50. Myokai F., Takashiba S., Lebo R., et al. A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor α gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment. Proc. Natl. Acad. Sci. USA. 96:1999;4518-4523.
51. Nadeau S., Rivest S. Regulation of the gene encoding tumor necrosis factor alpha (TNF-alpha) in the rat brain and pituitary in response in different models of systemic immune challenge. J. Neuropathol. Exp. Neurol. 58:1999;61-77.
52. Nill M.R., Oberyszyn T.M., Ross M.S., et al. Temporal sequence of pulmonary cytokine gene expression in response to endotoxin in C3H/HeN endotoxin-sensitive and C3H/HeJ endotoxin-resistant mice. J. Leukocyte Biol. 58:1995;563-574.
53. Ohlsson K., Bjork P., Bergenfeldt M., et al. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 348:1990;550-552.
54. Pahan K., Sheikh F.G., Namboodiri A.M., et al. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J. Clin. Invest. 100:1997;2671-2679.
55. Paxinos G., Watson C. The Rat Brain in Sterotaxic Coordinates. 1998;Academic Press, San Diego.
56. Perry V.H., Andersson P.B., Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci. 16:1993;268-273.
57. 14 C]inulin in rat. Neuroscience. 95:2000;577-592.
58. Quan N., Whiteside M., Kim L., et al. Induction of inhibitory factor κBα mRNA in the central nervous system after peripheral lipopolysaccharide administration: an in situ hybridization histochemistry study in the rat. Proc. Natl. Acad. Sci. USA. 94:1997;10985-10990.
59. Quan N., Whiteside M., Herkenham M. Time course and localization patterns of interleukin-1β messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience. 83:1998;281-293.
60. Righi M., Mori L., De Libero G., et al. Monokine production by microglial cell clones. Eur. J. Immunol. 19:1989;1443-1448.
61. Robbins D.S., Shirazi Y., Drysdale B.E., et al. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J. Immunol. 139:1987;2593-2597.
62. Robbins R.A., Sisson J.H., Springall D.R., et al. Human lung mononuclear cells induce nitric oxide synthase in murine airway epithelial cells in vitro: role of TNFα and IL-1β Am. J. Respir. Crit. Care Med. 155:1997;268-273.
63. Samad F., Bergtrom G., Amrani D.L. Regulation of plasminogen activation by interleukin-6 in human lung fibroblasts. Biochim. Biophys. Acta. 1221:1994;307-314.
64. Sawada M., Kondo N., Suzumura A., et al. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 491:1989;394-397.
65. Sebire G., Emilie D., Wallon C., et al. In vitro production of IL-6, IL-1 beta, and tumor necrosis factor-alpha by human embryonic microglial and neural cells. J. Immunol. 150:1993;1517-1523.
66. Shafit-Zagardo B., Sharma N., Berman J.W., et al. CSF-1 expression is upregulated in astrocyte cultures by IL-1 and TNF and affects microglial proliferation and morphology in organotypic cultures. Int. J. Dev. Neurosci. 11:1993;189-198.
67. Shalaby M.R., Waage A., Aarden L., et al. Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo. Clin. Immunol. Immunopathol. 53:1989;488-498.
68. Strijbos P.J., Rothwell N.J. Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J. Neurosci. 15:1995;3468-3474.
69. Sugaya K., Chou S., Xu S.J., et al. Indicators of glial activation and brain oxidative stress after intraventricular infusion of endotoxin. Brain Res. Mol. Brain Res. 58:1998;1-9.
70. Taupin V., Toulmond S., Serrano A., et al. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J. Neuroimmunol. 42:1993;177-185.
71. Tilders F.J., DeRijk R.H., Van Dam A.M., et al. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals. Psychoneuroendocrinology. 19:1994;209-232.
72. Tracey K.J., Beutler B., Lowry S.F., et al. Shock and tissue injury induced by recombinant human cachectin. Science. 234:1986;470-474.
73. Ulich T.R., Guo K.Z., Remick D., et al. Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6. J. Immunol. 146:1991;2316-2323.
74. Ulich T.R., Watson L.R., Yin S.M., et al. The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate. Am. J. Pathol. 138:1991;1485-1496.
75. Vallières L., Rivest S. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1β J. Neurochem. 69:1997;1668-1683.
76. Wakabayashi G., Gelfand J.A., Burke J.F., et al. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits. FASEB J. 5:1991;338-343.
77. Wang X., Yue T.L., Barone F.C., et al. Concomitant cortical expression of TNF-α and IL-1β mRNAs follows early response gene expression in transient focal ischemia. Mol. Chem. Neuropathol. 23:1994;103-114.
78. Wang X., Yue T.L., Young P.R., et al. Expression of interleukin-6, c-fos, and zif268 mRNAs in rat ischemic cortex. J. Cereb. Blood Flow Metab. 15:1995;166-171.
79. Wang X., Barone F.C., Aiyar N.V., et al. Interleukin-1 receptor and receptor antagonist gene expression after focal stroke in rats. Stroke. 28:1997;155-161.
80. Weller R.O., Engelhardt B., Phillips M.J. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol. 6:1996;275-288.
81. Wesselingh S.L., Levine B., Fox R.J., et al. Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response. J. Immunol. 152:1994;1289-1297.
82. Whitfield H.J. Jr., Brady L.S., Smith M.A., et al. Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol. Cell. Mol. Neurobiol. 10:1990;145-157.
83. Wong D., Dorovini-Zis K. Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J. Neuroimmunol. 39:1992;11-21.
84. Wong D., Dorovini-Zis K. Expression of vascular cell adhesion molecule-1 (VCAM-1) by human brain microvessel endothelial cells in primary culture. Microvasc. Res. 49:1995;325-339.
85. Xiao B.G., Link H. Immune regulation within the central nervous system. J. Neurol. Sci. 157:1998;1-12.
86. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
87. Xiong H., Nishibori T., Ohya S., et al. Involvement of various combinations of endogenous inflammatory cytokines in Listeria monocytogenes-induced expression of inducible nitric oxide synthase in mice. FEMS Immunol. Med. Microbiol. 16:1996;257-266.
88. Yamada K., Komori Y., Tanaka T., et al. Brain dysfunction associated with an induction of nitric oxide synthase following an intracerebral injection of lipopolysaccharide in rats. Neuroscience. 88:1999;281-294.
89. Zhao B., Schwartz J.P. Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives. J. Neurosci. Res. 52:1998;7-16.